Search

Search Funnelback University

Search powered by Funnelback
10 results 20 results 50 results
Relevance Date (Newest first) Date (Oldest first) Title (A-Z) Title (Z-A) Distance URL (A-Z) URL (Z-A) Shuffle
Your query has been expanded to `news stories` |u:www.enterprize.cam.ac.uk.  Search for `news stories` |u:www.enterprise.cam.ac.uk instead.
61 - 70 of 178 search results for `news stories` |u:www.enterprise.cam.ac.uk or `news stories` |u:www.enterprize.cam.ac.uk

  1. Fully-matching results

  2. BOADICEA: Calculating the risk of breast cancer – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/case-studies/boadicea-calculating-the-risk-of-breast-cancer/
    Thumbnail for BOADICEA: Calculating the risk of breast cancer – Cambridge Enterprise 11 Apr 2022: BOADICEA is a platform developed by researchers at the Department of Public Health and Primary Care that calculates the risk of breast cancer.

  3. New grafting technique published in Nature - Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/news/research-supported-by-cambridge-enterprise-and-ceres-agri-tech-published-in-nature/
    Thumbnail for New grafting technique published in Nature - Cambridge Enterprise 16 Mar 2022: New grafting techniqe supported by Cambridge Enterprise and Ceres Agri-Tech could combat Cavendish banana disease

  4. COBRAS Concrete Bridge Assessment Program – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/reagents/cobras-concrete-bridge-assessment-program/
    Thumbnail for COBRAS Concrete Bridge Assessment Program – Cambridge Enterprise 9 May 2022: COBRAS Concrete Bridge Assessment Program is a yield-line analysis software for assessing the ultimate load capacity of concrete structures.

  5. HappyShield: A simple, elegant solution to PPE scarcity – Cambridge…

    https://www.enterprise.cam.ac.uk/case-studies/happyshield-a-simple-elegant-solution-to-ppe-scarcity/
    Thumbnail for HappyShield: A simple, elegant solution to PPE scarcity – Cambridge Enterprise 11 Apr 2022: HappyShield provides a barrier from splashes and sprays of infected bodily fluids and can be cleaned and reused indefinitely.

  6. Cambridge Enterprise leads £1m investment in cancer care management…

    https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-leads-1m-investment-in-cancer-care-management-device-start-up/
    Thumbnail for Cambridge Enterprise leads £1m investment in cancer care management device start-up – Cambridge Enterprise 28 Apr 2022: Cambridge Enterprise leads £1 million investment in 52 North Health, a UK and US-based med-tech start-up.

  7. Rat CD45 monoclonal antibody YTH 24.5

    https://www.enterprise.cam.ac.uk/reagents/human-cd45-monoclonal-antibody-yth-24-5/
    Thumbnail for Rat CD45 monoclonal antibody YTH 24.5 9 May 2022: Hybridoma cell line producing YTH 24.5 antibodies raised against human CD45 which are rat monoclonal antibodies of the IgG2b isotype.

  8. Cambridge Enterprise co-leads £2.4m investment in spin-out developing …

    https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-co-leads-2-4m-investment-in-spin-out-developing-adc-cancer-therapeutics/
    Thumbnail for Cambridge Enterprise co-leads £2.4m investment in spin-out developing ADC cancer therapeutics – Cambridge Enterprise 14 Jun 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 14 June 2022. Cambridge Enterprise co-leads £2.4m investment in spin-out developing ADC cancer therapeutics. Share:. Spirea Limited, a University of Cambridge spin-out company created

  9. Knowledge exchange in southern Africa – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/case-studies/knowledge-exchange-teaching-and-learning-in-southern-africa/
    Thumbnail for Knowledge exchange in southern Africa – Cambridge Enterprise 11 Apr 2022: We ran a knowledge exchange programme on research commercialisation for three southern African universities in 2019.

  10. Human CD11a monoclonal antibody YTH 81.5

    https://www.enterprise.cam.ac.uk/reagents/human-cd11a-monoclonal-antibody-yth-81-5/
    Thumbnail for Human CD11a monoclonal antibody YTH 81.5 9 May 2022: Hybridoma cell line producing YTH 81.5 antibodies raised against human CD11a which are rat monoclonal antibodies of the IgG2a isotype.

  11. Joint Harvard-Cambridge spin-out closes $50m Series A to drive…

    https://www.enterprise.cam.ac.uk/news/joint-harvard-cambridge-spin-out-closes-50m-series-a-to-drive-biomolecular-condensate-drug-discovery/
    Thumbnail for Joint Harvard-Cambridge spin-out closes $50m Series A to drive biomolecular condensate drug discovery – Cambridge Enterprise 4 Jul 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 6 June 2022. Joint Harvard-Cambridge spin-out closes $50m Series A to drive biomolecular condensate drug discovery. Share:. a joint spin-out from the University of Cambridge and Havard

Refine your results

clear all

Date

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.